Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
Advanced search 
Year : 2021  |  Volume : 17  |  Issue : 75  |  Page : 643-648

Cardioprotective effect of plumbagin and amelioration of pro-inflammatory cytokines through suppression of Na+/K+-ATPase on myocardial ischemia

1 The Fourth Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
2 The Seventh Medical Center of PLA General Hospital, Beijing, China
3 Department of Cardiology, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China

Correspondence Address:
Guorong Zhang
The Fourth Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330003
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pm.pm_565_20

Rights and Permissions

Background: Ischemia heart disease in acute phase has formed Myocardial Infarction (MI) due to imbalance between the vascular supply of oxygen and nutrients and myocardial remands leads necrosis. Objective: Herein, we investigated the cardioprotective effect of plumbagin in isoprenaline hydrochloride (ISO)-induced inflammatory response and increase in antioxidant enzymes and Na+/K+-ATPase activity in MI rats. Materials and Methods: The animals were divided into four groups: Vehicle control group (0.1%), plumbagin group (25 mg/kg/b.w.), ISO group (85 mg/kg/b.w.) injected subcutaneously for 2 days at 24 h interval after a week to induce MI, and plumbagin (25 mg/kg/b.w.) by oral administration for 1 month. The inflammatory and cardiac markers were examined using ELISA kits. The oxidative markers, antioxidant markers, and Na+/K+-ATPase activity was detected using standard methods. Results: According to our results, plumbagin significantly increased the activities of creatine kinase and cardiac troponin T (cTnT). It significantly restored the levels of lipid peroxidation markers (thiobarbituric acid reactive substances [TBARS] and lipid hydroperoxide), increased the antioxidative enzymes (superoxide dismutase, catalase, glutathione [GSH] peroxidase, and the content of GSH), and decreased the levels of pro-inflammatory cytokines (tumor necrosis factor-α, interleukin-6, and nuclear factor kappa B). Histological studies also reveal the decreased inflammatory signs and tissue damages. Conclusion: Our results indicate that plumbagin increased antioxidant enzymes, reduced inflammatory response, and reduced Na+/K+-ATPase activity in rats with MI. Hence, we recommended that plumbagin confers effective cardioprotective activity against ISO-induced MI heart injury.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded83    
    Comments [Add]    

Recommend this journal